Establishment of clinical diagnosis model of Graves’ disease and Hashimoto’s thyroiditis

Table 1 Clinical feature of the study subjects

Items	GD n = 119	HT n = 78	P value
Gender (M/F)	41/78	9/69	< 0.001
Age	38.73 ± 13.73	37.65 ± 10.79	0.560
FT3	20.99 ± 14.36	14.31 ± 10.91	< 0.001
FT4	52.31 ± 30.26	40.27 ± 23.88	0.003
TSH	0.01 ± 0.03	0.02 ± 0.42	0.038
TGAb	362.52 ± 587.11	550.96 ± 757.63	0.050
TPOAb	226.37 ± 209.04	274.39 ± 477.62	0.335
TRAb	9.67 ± 10.68	5.75 ± 9.6	0.010
2-h RAIU	31.15 ± 16.75	22.79 ± 17.12	< 0.001
6-h RAIU	47.92 ± 20.79	32.82 ± 23.88	< 0.001
24-h RAIU	57.74 ± 20.44	38.49 ± 26.57	< 0.001
RAIU-AUC	1109.22 ± 433.67	753.13 ± 527.79	< 0.001

M: male; F: female; GD: Graves’ disease; HT: Hashimoto’s thyroiditis; FT3: free T3; FT4: free T4; TSH: thyroid stimulating hormone; TGAb: thyroglobulin antibody; TPOAb: thyroid peroxidase antibodies; TRAb: thyrotropin receptor antibody; RAIU: radioactive iodine uptake; AUC: area under the curve

ISSN: 1479-5876